# Vorapaxar and Lower Extremity Bypass Grafts

> **NCT02975583** · PHASE4 · WITHDRAWN · sponsor: **Vanderbilt University**

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DRUG:** Vorapaxar
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT02975583
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-10-01
- **Primary completion:** 2018-01-10
- **Final completion:** 2018-01-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** We could not secure adequate medication
- **Last updated:** 2018-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02975583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02975583, "Vorapaxar and Lower Extremity Bypass Grafts". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02975583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*